Literature DB >> 4790564

In vitro activity of tobramycin and gentamicin.

M R Britt, R A Garibaldi, J N Wilfert, C B Smith.   

Abstract

The in vitro antimicrobial activity of tobramycin and gentamicin was compared against 362 bacterial isolates. The minimal inhibitory concentration (MIC) of tobramycin was fourfold less than the MIC of gentamicin against most of 119 Pseudomonas organisms. Gentamicin and tobramycin had similar in vitro activity against Enterobacteriaceae and Staphylococcus aureus. Proteus rettgeri were commonly resistant to both tobramycin and gentamicin. The 10-mug tobramycin disc separated resistant (MIC >/=5 mug/ml) and susceptible (MIC <5 mug/ml) organisms in 359 of 362 tested. In disc diffusion testing, the tobramycin and gentamicin zone diameters were found to vary significantly with concentrations of magnesium ions in the media employed. The MIC of tobramycin varied with the size of the inoculum, and tobramycin was most effective at a neutral pH.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4790564      PMCID: PMC444298          DOI: 10.1128/AAC.2.3.236

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  High level transferable resistance to gentamicin.

Authors:  J L Witchitz; Y A Chabbert
Journal:  J Antibiot (Tokyo)       Date:  1971-02       Impact factor: 2.649

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Infection and antibiotic usage at Boston City Hospital, January 1970.

Authors:  J L Adler; J P Burke; M Finland
Journal:  Arch Intern Med       Date:  1971-03

4.  A study of the bacteriologic patterns of hospital infections.

Authors:  M J McNamara; M C Hill; A Balows; E B Tucker
Journal:  Ann Intern Med       Date:  1967-03       Impact factor: 25.391

5.  Relation between dose and levels of gentamicin in blood.

Authors:  R E Winters; K D Litwack; W L Hewitt
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  In vitro susceptibility testing with tobramycin.

Authors:  S Shadomy; C Kirchoff
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

7.  Tobramycin: in vitro activity and comparison with kanamycin and gentamicin.

Authors:  V E Del Bene; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

8.  In vitro studies of tobramycin, an aminoglycoside antibiotic.

Authors:  J Dienstag; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

9.  In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.

Authors:  M E Levison; R Knight; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

10.  Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.

Authors:  R D Meyer; L S Young; D Armstrong
Journal:  Appl Microbiol       Date:  1971-12
View more
  8 in total

Review 1.  Antibacterial Drugs today: II.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Local release of antibiotics for surgical site infection management using high-purity calcium sulfate: an in vitro elution study.

Authors:  Sean S Aiken; John J Cooper; Hannah Florance; Matthew T Robinson; Stephen Michell
Journal:  Surg Infect (Larchmt)       Date:  2014-08-22       Impact factor: 2.150

3.  Tobramycin nephrotoxicity. A prospective clinical study.

Authors:  A Coca; J Blade; A Martinez; F Segura; E Soriano; M Ribas-Mundo
Journal:  Postgrad Med J       Date:  1979-11       Impact factor: 2.401

4.  Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.

Authors:  E L Anderson; P K Gramling; P R Vestal; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

5.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

6.  Antibiotic blood concentrations in patients successfully treated with tobramycin.

Authors:  M Fiala; S N Chatterjee
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

7.  Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.

Authors:  W R Lockwood; L A Lawson
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

8.  Use of gentamicin in the isolation of subgroup A Chlamydia.

Authors:  B B Wentworth
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.